The characterization of human T1D anti-HIP antibodies, and their use to isolate in vivo circulating anti-HIPs, will be a future goal to further our understanding of the roles of HIPs in diabetes. This evidence concerns the gene ISYNA1 and type 1 diabetes mellitus.